Achieve Life Sciences IncACHV
▼ NegativeCapitalrelevance
Q2 GAAP EPS of -$0.80 missed estimates by $0.64.

Achieve Life Sciences reported second-quarter 2026 GAAP earnings per share of -$0.80, missing analyst estimates by $0.64. As of June 30, 2026, the company held cash, cash equivalents, and marketable securities totaling $187.3 million.
Achieve Life Sciences IncQ2 GAAP EPS of -$0.80 missed estimates by $0.64.